Criteria Caixa S.A.U. bought a new position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 72,087 shares of the company’s stock, valued at approximately $6,553,000. Colgate-Palmolive makes up about 0.7% of Criteria Caixa S.A.U.’s investment portfolio, making the stock its 18th largest position.
Several other institutional investors also recently made changes to their positions in the stock. Personal CFO Solutions LLC purchased a new stake in shares of Colgate-Palmolive in the 1st quarter worth about $285,000. Vision Capital Management Inc. purchased a new stake in shares of Colgate-Palmolive in the 1st quarter worth about $322,000. Autumn Glory Partners LLC boosted its position in shares of Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company’s stock worth $851,000 after buying an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. purchased a new stake in shares of Colgate-Palmolive in the 1st quarter worth about $2,166,000. Finally, Penserra Capital Management LLC boosted its position in shares of Colgate-Palmolive by 398.6% in the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after buying an additional 8,515 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research firms recently commented on CL. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a research note on Friday. Barclays cut their target price on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Finally, UBS Group cut their target price on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a research note on Wednesday. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $92.21.
Colgate-Palmolive Stock Up 0.2%
CL opened at $77.99 on Friday. The firm has a 50 day moving average price of $82.56 and a 200 day moving average price of $87.88. The company has a market cap of $63.03 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 4.29 and a beta of 0.34. Colgate-Palmolive Company has a 1 year low of $77.09 and a 1 year high of $102.61. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.91 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- How to Short a Stock in 5 Easy Steps
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.